# A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra

> **NCT03255798** · NA · TERMINATED · sponsor: **Glaukos Corporation** · enrollment: 7 (actual)

## Conditions studied

- Glaucoma, Open-Angle

## Interventions

- **DEVICE:** G2 and G3

## Key facts

- **NCT ID:** NCT03255798
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-01
- **Primary completion:** 2019-06-06
- **Final completion:** 2019-06-06
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2022-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03255798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03255798, "A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03255798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*